SEC Company Response from CAMTEK LTD (CAMT) (CIK 0001109138) (CAMT) — Sep 14, 2006
CAMTEK LTD (CAMT) (CIK 0001109138)
Date: Sept. 14, 2006 · CIK: 0001109138 · Accession: 0000922423-06-001204
AI Filing Summary & Sentiment
Referenced dates: August 18, 2006
Show Raw Text
CORRESP
1
filename1.htm
Correspondence
KRAMER LEVIN NAFTALIS
& FRANKEL LLP
September
13,
2006
VIA
EDGAR AND BY FEDERAL EXPRESS
Mr.
Gary
R. Todd
Division
of Corporation Finance
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F
Street, N.E.
Washington,
D.C. 20549
Re:
Camtek
Ltd.
Form 20-F for the fiscal year ended
December 31, 2005
Filed June 29, 2006
File No. 0-30664
Dear
Mr.
Todd:
Reference
is made to the letter dated August 18, 2006 (the “Comment
Letter”)
to Mr.
Rafi Amit, Chairman of the Board and Chief Executive Officer of Camtek Ltd.
(the
“Company”),
setting forth the comments of the staff of the Division of Corporation Finance
of the Securities and Exchange Commission (the “Staff”)
regarding the above-referenced Form 20-F filed by the Company on June 29, 2006
(the “Form
20-F”)
with
the Securities and Exchange Commission (the “Commission”).
This
letter sets forth the Company’s responses to the Staff’s comments. For your
convenience, the Staff’s comments contained in the Comment Letter have been
restated below in their entirety, with the responses to each comment set forth
immediately under the applicable comment. The numbered paragraphs in this letter
correspond to the numbered paragraphs of the Comment Letter. We are also sending
courtesy copies of this letter to you by Federal Express.
Form
20-F as of December 31, 2005
Item
5. Operating
and Financial Review and Prospects, page 22
Liquidity
and Capital Resources, page 26
1.
We
see that you sold ordinary shares and warrants in April 2006. Tell
us
about the terms and conditions of those warrants, including but not
limited to, registration provisions, liquidated damages clauses,
non-cash
exercise provisions and any circumstances
that
KRAMER
LEVIN NAFTALIS & FRANKEL LLP
Mr.
Gary
R. Todd
September
13, 2006
Page
2
may
lead to changes in the exercise price. Also describe how you have accounted
for
those warrants. In that regard, fully describe how you considered and applied
the requirements of SFAS 133 and EITF 00-19 in evaluating whether those warrants
are derivatives that should be accounted as assets or liabilities at fair
value.
On
April
26, 2006, the Company raised $15 million by issuing 2,525,252 ordinary shares
at
a price of $5.94 per share in a private placement to Israeli institutional
investors. The private placement also included warrants that are exercisable
into 1,262,626 ordinary shares at a price of $6.83 per share during a period
of
four years. The private placement was exempt from registration in the United
States pursuant to the exemption from registration provided by Regulation S
as a
Category 1 transaction within the meaning of section 903(b)(ii)(a) of the SEC
rules under the Securities Act of 1933. The warrants issued in April 2006 have
been classified in equity for the following reasons:
a. There
are
no registration rights attached to the warrants or the underlying ordinary
shares since the shares were not subject to resale limitations under Regulation
S and could be resold in Israel on the Tel Aviv Stock Exchange under Rule 904.
If the Israeli institutional investors exercise the warrants, the shares
underlying these warrants would be exempt from registration under Regulation
S,
and in Israel the shares are automatically registered upon issuance of the
warrants. Accordingly, there are no liquidated damages clauses attached to
the
shares or warrants since no registration was required.
b. There
are
no adjustments to be made to the exercise price of the warrants except for
those
which would fall within the category of equity restructuring as defined in
the
glossary of FASB 123R.
c. The
warrants contain only customary terms and there are no provisions in the warrant
certificate that violate any of the provisions prescribed in EITF 00-19
paragraphs 12-32 that would preclude equity classification.
Based
on
the above the Company believes that equity classification of the warrants is
appropriate.
Item
8. Financial
Statements, page 42
2.
We
see that the audited financial statements are incorporated by reference
to
a Form 6-K. The audited financial statements should also be included
in
the annual report on Form 20-F. Refer to Item 8A to Form 20-F. Please
apply in future filings.
In
future
filings, the Company will comply with the Staff’s request.
KRAMER
LEVIN NAFTALIS & FRANKEL LLP
Mr.
Gary
R. Todd
September
13, 2006
Page
3
Form
6-K dated April 6, 2006
Note
9 Convertible
Loan, page F-13
3.
We
see that in August, 2005 you issued a convertible note. Please tell
us how
you evaluated and applied the provisions of SFAS 133 and EITF 00-19
in
concluding that the conversion feature was not a derivative that should be
bifurcated and accounted for separately at fair value. Your response
should fully describe the terms and provisions of the financing and
explain how you considered those terms and provisions in reaching
your
conclusions about the requirements of
literature.
As
described in Note 9 to the Company’s consolidated financial statements, on
August 23, 2005, the Company raised $5 million pursuant to the issuance of
notes
evidencing a convertible loan from FIMI Opportunity Fund L.P and FIMI Israel
Opportunity Fund, Limited Partnership (collectively, “FIMI”).
The
loan is payable in three equal annual payments starting at the third anniversary
of the closing date. The loan bears annual interest of Libor + 2.1%. The
interest is payable every three months. Conversion of the notes, in whole or
in
part, is optional at any given business day after the closing date. The
conversion price is $5.50 per share, however, in the event that the average
closing price of the Company's shares as reported on NASDAQ for the 60
consecutive trading days immediately preceding the first and second anniversary
of the loan agreement closing date is lower than the conversion price in effect
on such date, the conversion price in effect on such date shall be reduced
to
the higher of the average closing price and $2.00.
In
addition, in the event that the Company (a) is acquired in its entirety or
(b)
is consolidated or merges with or into any third party in a transaction pursuant
to which the Company’s shareholders immediately prior to such transaction do not
hold at least 51% of the shares of the surviving entity immediately following
such transaction, then if any such transaction is consummated prior to the
third
anniversary of the closing date, at an effective price per share, which, when
multiplied by 70% (the "Exit Discounted PPS"), is lower than the conversion
price in effect on such date, then the conversion price shall automatically
be
adjusted to equal the Exit Discounted PPS; provided, however, that if such
Exit
Discounted PPS is lower then $2.00, the Company may issue shares upon conversion
of the notes on the basis of a conversion price of $2.00 and pay FIMI, upon
such
conversion, an additional amount equal to the difference between (i) the value
of the shares that would have been issued had the conversion price been equal
to
the Exit Discounted PPS and (ii) the value of the shares that were issued on
the
basis of the $2.00 conversion price. If such exit transaction is consummated
following the third anniversary of the closing date, the same mechanism would
apply; provided, however, that the "70%" number set forth above would be
replaced by "65%".
In
addition, at any time after the first anniversary of the closing date, the
holders of the notes shall, subject to the provisions of a registration rights
agreement, be entitled to request that
KRAMER
LEVIN NAFTALIS & FRANKEL LLP
Mr.
Gary
R. Todd
September
13, 2006
Page
4
the
Company use its best efforts to effect a registration of the holders' securities
under the Securities Act of 1933.
The
Company evaluated the provisions of SFAS 133 and EITF 00-19 as follows:
a. The
Company examined the provisions of EITF 05-02. Based on the terms of the notes
described above, the Company determined that the notes should not be considered
a conventional convertible debt instrument. Based on the provisions of the
notes, the Company identified two embedded derivatives to be evaluated for
bifurcation.
1.
Conversion
option (the "conversion
option")
that entitles the holders to convert the debt to equity. Settlement
is
only by physical delivery of the notes for shares and there is no
event
that could require the Company to pay cash to settle the conversion
option. The conversion price of such option may be adjusted after
the
first and second anniversary to the higher of $2.00 or the average
per
share price over 60 consecutive trading immediately preceding the
respective anniversaries. In no event will the exercise price be
lower
than $2.00.
2.
A
merger or change in control ("exit")
derivative for the conversion to shares at an exercise price that
is 70%
(or 65% if exit is consummated after the third anniversary) of the
exit
per share price. If 70% of the exit price is lower than $2.00, the
Company
can settle the derivative in shares based on $2.00 per share and
a cash
amount equal to the difference between the value of the shares issued
using the conversion price of $2.00 and the number of shares that
would
have been issued had the conversion price been 70% of the exit price.
The
Company concluded that (1) the embedded derivative meets the conditions in
paragraph 12 of FASB 133 and (2) that the embedded derivative meets the
definition of a derivative in paragraph 6 of FASB 133.
b. As
a next
step the Company considered the scope exception in paragraph 11(a) of FASB
133.
The Company examined the terms of the embedded derivatives in accordance with
EITF 00-19 including the provisions of paragraph 14-32 of that EITF (consistent
with its conclusion that the convertible debt is not conventional), to determine
whether the conversion option and the exit derivative were derivatives that
require bifurcation as follows:
KRAMER
LEVIN NAFTALIS & FRANKEL LLP
Mr.
Gary
R. Todd
September
13, 2006
Page
5
Analysis
for the conversion option
1.
"The
contract permits the company to settle in unregistered shares.” (Par.
14-18).
Since
the
Company will register the shares only on the basis of "best efforts" without
any
specific time period or any penalties for failure to register the shares within
a defined period, settlement is considered within the Company's control and
equity classification is not precluded.
2.
“The
company has sufficient authorized and unissued shares available to
settle
the contract after considering all other commitments that may require
the
issuance of stock during the maximum period the derivative contract
could
remain outstanding.” (Par.
19).
There
are
100,000,000 authorized shares and 28,000,000 issued and outstanding shares.
The
maximum amount of shares issuable under the conversion option is 2,500,000
shares due to the $2.00 floor on the conversion price.
3.
“The
contract contains an explicit limit on the number of shares to be
delivered in a share settlement.” (Par.
20-24).
The
total
number of shares to be issued pursuant to the agreement is limited due to the
minimum conversion price of $2.00.
4.
“There
are no required cash payments to the counterparty in the event the
company
fails to make timely filings with the SEC.” (Par.
25).
As
was
described above, no such payments are required.
KRAMER
LEVIN NAFTALIS & FRANKEL LLP
Mr.
Gary
R. Todd
September
13, 2006
Page
6
5.
“There
are no required cash payments to the counterparty if the shares
initially
delivered upon settlement are subsequently sold by the counterparty
and
the sales proceeds are insufficient to provide the counterparty
with full
return of the amount due (that is, there are no cash settled "top-off"
or
"make-whole" provisions).” (Par.
26).
There
are
no such rights granted to the investors in the loan agreement.
6.
“The
contract requires net-cash settlement only in specific circumstances
in
which holders of shares underlying the contract also would receive
cash in
exchange for their shares.” (Par. 27-
28).
There
are
no such provisions in the loan agreement.
7.
“There
are no provisions in the contract that indicate that the counterparty
has
rights that rank higher than those of a shareholder of the stock
underlying the contract.” (Par.
29-31).
There
are
no such provisions in the loan agreement.
8.
“There
is no requirement in the contrac